drugset / Trial / NCT01692301
Study of the Safety and Efficacy of LCZ696 on Arterial Stiffness in Elderly Patients With Hypertension
RandomizedParallel-groupDouble-blindTreatment
Summary
The study examined the efficacy of LCZ696 in comparison to the ARB olmesartan on Central Aortic Systolic Blood Pressure (CASP) and other measures of central hemodynamics and arterial stiffness in elderly patients with an elevated systolic blood pressure (SBP) and widened pulse pressure (PP).
Timeline
- Start
- 2012-12
- Primary completion
- 2015-04
- Completion
- 2015-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LCZ696 | Unknown | 400 mg | — |
| Subject | Olmesartan | Other / unclassified | 40 mg | — |
| Background | Amlodipine | Other / unclassified | 2.5 mg | — |
| Background | Amlodipine | Other / unclassified | 5 mg | — |
| Background | Hydrochlorothiazide | Unknown | 6.25 mg | — |
| Background | Hydrochlorothiazide | Unknown | 12.5 mg | — |
| Background | Hydrochlorothiazide | Unknown | 25 mg | — |